The decision to stop marketing Exubera is due to the product falling short of company and customer expectations. Pfizer will support current Exubera patients until 16 January 2008 as they transfer to other glucose-lowering therapies, but after that Exubera will no longer be promoted or sold.
Healthcare professionals should not start any new patients on Exubera. Patients currently using Exubera should be transfered to alternative glucose-lowering medications.
Further information: Pfizer 01304 616161